Investor Relations

Investor Relations

Profile

Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. It is the only North American company to offer biosimilars on market in Europe and Australia. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately 19,000 employees worldwide and generated approximately $4.5 billion in net sales in 2014. Learn more >


PROPOSED MERGER WITH PFIZER INC.

View Pfizer Inc. and Hospira, Inc. February 5, 2015 Press Release
View Hospira’s Definitive Proxy Statement for the May 13, 2015 Special Meeting of Stockholders

Investor Presentations

Investor Presentations

Annual Report

2014 Annual Report

Stock Quote

ExchangeNYSE
Current Price$88.95
Change (%) Stock is Up 0.06 (0.07%)
High$88.99
Low$88.82
Volume1,085,086
Data as of 07/02/15 4:03 p.m. ET
Minimum 20 minute delay
Refresh quote

Stock Chart

Stock chart for: 03NA000000HSP

Recent News

DateTitle 
06/10/15New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™Printer Friendly Version
06/02/15ANVISA Approves First Infliximab Biosimilar in BrazilPrinter Friendly Version
05/20/15Hospira, Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to Discuss the Future of Biosimilars in the United StatesPrinter Friendly Version

Contact Information

Hospira Investor Relations
224-212-2711
Hospira.InvestorRelations@hospira.com
www.hospirainvestor.com




Tax Information for Shareholders

Tax/Cost Basis InformationDownload Documentation 
U.S. Tax Reporting StatementDownload Documentation 
Canadian Tax Reporting StatementDownload Documentation 

Transfer Agent

Computershare
P.O. Box 30170
College Station, TX 77842-3170
781-575-4677 (Outside the US & Canada)
800-821-1238 (US & Canada)
Home page: www.computershare.com/investor
Contact Site: www.computershare.com/contactus


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.